Pacer Advisors, Inc. Fulgent Genetics, Inc. Transaction History

Pacer Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$29.23 - $40.28 $2.8 Million - $3.85 Million	95,645 Added 19.63%	582,853 $17.4 Million
Q3 2022 Oct 18, 2022	BUY	$37.92 - $63.74 $4.67 Million - $7.86 Million	123,265 Added 33.87%	487,208 $18.6 Million
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $3.01 Million - $3.94 Million	62,794 Added 20.85%	363,943 $19.8 Million
Q1 2022 Apr 05, 2022	BUY	$49.85 - $96.11 $7.71 Million - $14.9 Million	154,566 Added 105.45%	301,149 $18.8 Million
Q4 2021 Feb 03, 2022	BUY	$77.3 - $105.0 $4.48 Million - $6.08 Million	57,941 Added 65.37%	146,583 $14.7 Million
Q3 2021 Oct 15, 2021	BUY	$74.87 - $110.87 $734,624 - $1.09 Million	9,812 Added 12.45%	88,642 $7.97 Million
Q2 2021 Jul 21, 2021	BUY	$66.8 - $100.45 $5.27 Million - $7.92 Million	78,830 New	78,830 $7.27 Million

198

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $504M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.